The modified Glasgow Prognostic Score (mGPS), a widely used composite score including CRP and serum ALB to estimate postoperative outcome in cancer patients, has been shown to be a predictor of mortality among patients undergoing chemotherapy for unresectable colorectal cancer [81]. The gene discussed is ALB; the disease is cancer.